QGEN
Qiagen NVNYSE
Healthcare • Diagnostics & Research
Updated 1 day ago
Coverage limited
Factor tilt: Balanced Mid Cap
$45.44+0.29%
Close Oct 13, 2026
- Market cap
- $9.44B
- 1 month
- +8.5%
- 3 months
- +10.2%
- 1 year
- -3.0%
- Dividend, last 12 mo
- $0.35 · 0.77% yield
- Last ex-date
- Jul 7, 2026 · $0.35
- Short interest
- 7.7M sharessettled Sep 30, 2026 · +0.2% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if QGEN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: UNKNOWN
3 top institutions tracked
as of 2026-Q2 (filed 2026-08-13)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
337 filers reported a long position in QGEN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $484.2M | 12.4M | -13.6% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $444M | 11.4M | +34.7% |
| PRINCIPAL FINANCIAL GROUP INC | $260M | 6.6M | +120,281.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $240.2M | 6.2M | +1.7% |
| BlackRock, Inc. | $230.9M | 5.9M | +12.5% |
| MORGAN STANLEY | $197.2M | 5M | +20.3% |
| EARNEST PARTNERS LLC | $178.8M | 4.6M | +18.2% |
| GOLDMAN SACHS GROUP INC | $173.7M | 4.4M | +219.4% |
| NORGES BANK | $168M | 4.3M | — |
| MILLENNIUM MANAGEMENT LLC | $150.4M | 3.8M | +543.3% |
Get the Full Analysis for QGEN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.